ALGS
ALGS
Positions held
Your positionsALGS isn't in your positions.
Add it to see shares, cost, and P&L here.
Fundamentals
| Market cap | — | Enterprise value | — | Trailing P/E | — | Forward P/E | — |
| PEG | — | Price / book | — | Beta | — | Dividend yield | — |
| Revenue growth | — | Earnings growth | — | Gross margin | — | Operating margin | — |
| Profit margin | — | ROE | — | ROA | — | Debt / equity | — |
| Current ratio | — | Free cash flow | — | Analyst recommendation | — | Mean target | — |
| 52w high | — | 52w low | — |
Quarterly
No data yet.
Yearly (6y)
No data yet.
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-10-05 · Aligos Therapeutics Announces Five Abstracts Accepted for Presentation at The Liver Meeting® 2026
2026-09-02 · Aligos Therapeutics to Present at the Cantor Global Healthcare Conference
2026-09-02 · Aligos Therapeutics Shares Rise 7.6% Premarket Following Recent Company Updates
2026-08-06 · Aligos Therapeutics Reports Recent Business Progress and Second Quarter 2026 Financial Results
2026-07-30 · Aligos Therapeutics to Announce 2nd Quarter 2026 Financial Results on August 6, 2026
2026-07-13 · Aligos Therapeutics Completes Enrollment in Phase 2 Study of Potential Chronic Hepatitis B Treatment
Price (daily)
Full chart · RSI · MACD · patterns